The results obtained in experimental animals confirmed these findings and the weekly injection of 1-PPA was effective to markedly reduce the features of NASH not only in wild type mice but also in SerpinB3 overexpressing mice. Here, SERPINB3 is linked to metabolic dysfunction-associated steatohepatitis.